In expert hands, EUS-GBD with nasobiliary drains is comparable to percutaneous GB
drainage in poor operative candidates with acute cholecystitis [Jang-et-al, Gastro-12].
Preliminary data on long-term outcomes of EUS-GBD using standard tubular SEMS or novel
LAMS are promising. However, the longest median follow-up reported after EUS-GBD with
either type of stent is one year. Longer term data are necessary to establish LAMS
EUS-GBD as a definitive therapy in poor opearative risk patients with gallbladder
disease.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.